Purdue Partnering 2005-2012
General Article (Non-News)
(Newsbox) 16-Jul-2012
Bharat Book introduces a report " Purdue Partnering 2005-2012 " This report provides all the information you require to better understand Pfizer and its partnering interests and activities over the past five years.
HTML clipboardThe Partnering Agreements with Purdue report provides an in-depth insight into  the partnering interests and activites of one of the worlds leading biopharma  companies.
  This report provides all the information you require to better understand Pfizer  and its partnering interests and activities over the past five years.
  On demand company reports are prepared upon purchase to ensure inclusion of the  most up to date deal and company data.
  The report will be delivered in PDF format within 3 working days of receipt of  order. If print or CD-Rom version purchased, the report will be sent by courier  using express service.
  http://www.bharatbook.com/healthcare-market-research-reports/purdue-partnering-2005-2012.html
  
  Description
  This report provides all the information you require to better understand Purdue and its partnering interests and  activities over the past seven years.
  
  One of the key aspects of partnering is finding those companies that are  potential partners for the development and commercialization of the next  generation of therapies as developed by innovative biopharma R&D companies. A  lot of resources are spent on finding partners, identifying their interests and  making contact to initiate discussions.
  
  Using this report, dealmakers will effectively and efficiently target their  partnering activities to deliver the company’s business development objectives.
  
  The initial chapters of this report provide an orientation of bigpharma’s  dealmaking and business activities. Chapter 1 provides an introduction to the  report, whilst chapter 2 lists the top 50 leading biopharma companies based on  2010 pharmaceutical revenues and their respective partnering activity. Chapter 3  provides an overview of the leading partnering and M&A 2005 to present date  based on headline value.
  
  Chapter 4 provides details on how to approach bigpharma companies with  partnering opportunities whilst chapter 5 lists forthcoming partnering events  and conferences where bigpharma companies will be present to discuss  opportunities face to face.
  
  The main body of the report is provided in chapter 6. A profile of the company  provides everything required to assess the suitability of a company as a  prospective partner. This includes a company overview, partnering interests,  partnering activity according to deal type, industry sector, phase of  development, and therapy area. The profile also includes in-depth contact  information for individuals within the business development function.
  
  The deals are listed by deal type, stage of development and therapy focus,  allowing easy access to deals and alliances of interest. Every deal record links  to an online, live version of the deal record at the Current Agreements deals  and alliances database. Where available, deal records also include the contract  document as disclosed at the SEC.
  
  One of the key aspects of partnering is conducting due diligence on a partner to  determine under what terms a prospective partner agrees to a partnering  relationship.
  
  Understanding the flexibility of prospective partners’ negiotated deals terms  provides critical insight into the negotiation process in termsof what you can  expect to achieve during the negotiation of terms. Whilst many smaller companies  will be seeking details of the payments clauses, the devil is in the detail in  terms of how payments are triggered – contract documents provide this insight  where press releases and databases do not.
  
  In addition, contract documents provide the answers to numerous questions about  a prospective partner’s flexibility on a wide range of important issues, many of  which will have a significant impact on each parties ability to derive value  from the deal.
  
  In summary, the report provides the user with the tools to make successful  contact with the right partners effectively and efficiently.
  
  Benefits
  Partnering Agreements with Purdue report provides the user with the  following key benefits:
  * Detailed company profile of the company 
  * Partnering interests and therapy focus revealed 
  * Partnering activity since 2005 – number of deals per year 
  * Partnering activity for 2005-present
  * Activity by deal type
  * Activity by phase of development
  * Activity by therapeutic area 
  * List of recent partner companies 
  * Detailed listing of all partnering deals since 2005 
  * Comprehensive access to actual contracts entered into by the company and its  partners* 
  * Insight into the terms included in a partnering agreement 
  * Understand the key deal terms the company has agreed in previous deals 
  * Undertake due diligence to assess suitability of your proposed deal terms for  partner companies 
  *Subject to being published via regulatory requirements of the Securities  Exchange Commission.
  
  For more information kindly visit : 
  Purdue Partnering 2005-2012
  
  Or
  
  Bharat Book Bureau
  Tel: +91 22 27810772 / 27810773
  Fax: + 91 22 27812290
  Email: info@bharatbook.com
  Website: www.bharatbook.com
  Follow us on twitter:  http://twitter.com/#!/Sandhya3B
  Our Blogs:  http://in.linkedin.com/in/bharatbook
  http://healthcareraj.blogspot.com/
Contact Info
Tag Cloud
Categories
This release was submitted by a Newsbox user. Any communication related to the content of this release should be sent to the release submitter.
